FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113128219> ?p ?o ?g. }

• W2113128219 endingPage "8576" @default.
• W2113128219 startingPage "8561" @default.
• W2113128219 abstract "Abstract Purpose: Human reovirus type 3 has been proposed to kill cancer cells with an activated Ras signaling pathway. The purpose of this study was to investigate the efficacy of reovirus in immunocompetent glioma animal models and safety/toxicity in immunocompetent animals, including nonhuman primates. Experimental Design: Racine glioma cells 9L and RG2 were implanted s.c. or intracranially in Fisher 344 rats with or without reovirus antibodies, followed by treatment of reovirus. To study whether reovirus kills contralateral tumors in the brain and to determine viral distribution, we established an in situ dual tumor model followed by reovirus intratumoral inoculation only into the ipsilateral tumor. To evaluate neurotoxicity/safety of reovirus, Cynomolgus monkeys and immunocompetent rats were given intracranially with reovirus, and pathological examination and/or behavioral studies were done. Viral shedding and clinical biochemistry were systematically studied in monkeys. Results: Intratumorally given reovirus significantly suppressed the growth of both s.c. and intracranially tumors and significantly prolonged survival. The presence of reovirus-neutralizing antibodies did not abort the reovirus’ antitumor effect. Reovirus inhibited glioma growth intracranially in the ipsilateral but not the contralateral tumors; viral load in ipsilateral tumors was 15 to 330-fold higher than the contralateral tumors. No encephalitis or behavioral abnormalities were found in monkeys and rats given reovirus intracranially. No treatment-related clinical biochemistry changes or diffuse histopathological abnormality were found in monkeys inoculated intracranially with Good Manufacturing Practice prepared reovirus. Microscopic changes were confined to the region of viral inoculation and were dose related, suggesting reovirus intracranially was well tolerated in nonhuman primates. Conclusions: These data show the efficacy and safety of reovirus when it is used in the treatment of gliomas in immunocompetent hosts. Inoculation of reovirus into the brain of nonhuman primates did not produce significant toxicities." @default.
• W2113128219 created "2016-06-24" @default.
• W2113128219 creator A5014311010 @default.
• W2113128219 creator A5016244575 @default.
• W2113128219 creator A5016518015 @default.
• W2113128219 creator A5020493393 @default.
• W2113128219 creator A5025139916 @default.
• W2113128219 creator A5041202163 @default.
• W2113128219 creator A5050395090 @default.
• W2113128219 creator A5052809255 @default.
• W2113128219 creator A5057475704 @default.
• W2113128219 creator A5057479940 @default.
• W2113128219 creator A5061341368 @default.
• W2113128219 creator A5063653533 @default.
• W2113128219 creator A5066797726 @default.
• W2113128219 creator A5073935866 @default.
• W2113128219 creator A5078521568 @default.
• W2113128219 creator A5079074945 @default.
• W2113128219 creator A5082185641 @default.
• W2113128219 creator A5082291945 @default.
• W2113128219 creator A5088103390 @default.
• W2113128219 creator A5089107486 @default.
• W2113128219 date "2004-12-15" @default.
• W2113128219 modified "2023-10-02" @default.
• W2113128219 title "Efficacy and Safety Evaluation of Human Reovirus Type 3 in Immunocompetent Animals" @default.
• W2113128219 cites W1558969188 @default.
• W2113128219 cites W1559374697 @default.
• W2113128219 cites W1601108467 @default.
• W2113128219 cites W1749496846 @default.
• W2113128219 cites W1968008033 @default.
• W2113128219 cites W1975480856 @default.
• W2113128219 cites W1978795170 @default.
• W2113128219 cites W1980309655 @default.
• W2113128219 cites W1982811896 @default.
• W2113128219 cites W1986599407 @default.
• W2113128219 cites W1988365044 @default.
• W2113128219 cites W1992610170 @default.
• W2113128219 cites W1999083178 @default.
• W2113128219 cites W2012049306 @default.
• W2113128219 cites W2015246305 @default.
• W2113128219 cites W2016138321 @default.
• W2113128219 cites W2017169966 @default.
• W2113128219 cites W2027958699 @default.
• W2113128219 cites W2036589843 @default.
• W2113128219 cites W2053034580 @default.
• W2113128219 cites W2058721062 @default.
• W2113128219 cites W2066890949 @default.
• W2113128219 cites W2070081328 @default.
• W2113128219 cites W2071260213 @default.
• W2113128219 cites W2074762435 @default.
• W2113128219 cites W2075874065 @default.
• W2113128219 cites W2078484077 @default.
• W2113128219 cites W2085747648 @default.
• W2113128219 cites W2090599158 @default.
• W2113128219 cites W2093953371 @default.
• W2113128219 cites W2114406100 @default.
• W2113128219 cites W2115921134 @default.
• W2113128219 cites W2128415522 @default.
• W2113128219 cites W2132191840 @default.
• W2113128219 cites W2146050626 @default.
• W2113128219 cites W2148795794 @default.
• W2113128219 cites W2150701651 @default.
• W2113128219 cites W2316629097 @default.
• W2113128219 doi "https://doi.org/10.1158/1078-0432.ccr-04-0940" @default.
• W2113128219 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15623640" @default.
• W2113128219 hasPublicationYear "2004" @default.
• W2113128219 type Work @default.
• W2113128219 sameAs 2113128219 @default.
• W2113128219 citedByCount "73" @default.
• W2113128219 countsByYear W21131282192012 @default.
• W2113128219 countsByYear W21131282192013 @default.
• W2113128219 countsByYear W21131282192014 @default.
• W2113128219 countsByYear W21131282192015 @default.
• W2113128219 countsByYear W21131282192016 @default.
• W2113128219 countsByYear W21131282192017 @default.
• W2113128219 countsByYear W21131282192018 @default.
• W2113128219 countsByYear W21131282192019 @default.
• W2113128219 countsByYear W21131282192020 @default.
• W2113128219 countsByYear W21131282192021 @default.
• W2113128219 countsByYear W21131282192022 @default.
• W2113128219 countsByYear W21131282192023 @default.
• W2113128219 crossrefType "journal-article" @default.
• W2113128219 hasAuthorship W2113128219A5014311010 @default.
• W2113128219 hasAuthorship W2113128219A5016244575 @default.
• W2113128219 hasAuthorship W2113128219A5016518015 @default.
• W2113128219 hasAuthorship W2113128219A5020493393 @default.
• W2113128219 hasAuthorship W2113128219A5025139916 @default.
• W2113128219 hasAuthorship W2113128219A5041202163 @default.
• W2113128219 hasAuthorship W2113128219A5050395090 @default.
• W2113128219 hasAuthorship W2113128219A5052809255 @default.
• W2113128219 hasAuthorship W2113128219A5057475704 @default.
• W2113128219 hasAuthorship W2113128219A5057479940 @default.
• W2113128219 hasAuthorship W2113128219A5061341368 @default.
• W2113128219 hasAuthorship W2113128219A5063653533 @default.
• W2113128219 hasAuthorship W2113128219A5066797726 @default.
• W2113128219 hasAuthorship W2113128219A5073935866 @default.
• W2113128219 hasAuthorship W2113128219A5078521568 @default.
• W2113128219 hasAuthorship W2113128219A5079074945 @default.

• next